DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Sumitomo Chemical India Limited — Change in Director(s)

NSE 1 hr ago·27 Jul 2026, 8:06 am

Sumitomo Chemical India

Sumitomo Chemical India Limited has announced a change in its board of directors. The company has informed the stock exchanges about the modification in its directorship, though the specific details regarding the outgoing and incoming individuals have not been disclosed in the public notice.

This development is a standard corporate governance update that generally does not impact the company's core business operations or financial performance. For investors, it is a routine administrative change rather than a strategic shift.

Investors should monitor the company's future regulatory filings to understand the full context of this change. It is advisable to wait for official disclosures to assess if this transition involves any significant changes in the company's strategic direction.